Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
EPS (Diluted)
Tandem Diabetes Care Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
24%
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Tandem Diabetes Care Inc's EPS (Diluted)?
EPS (Diluted)
-2.2
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's EPS (Diluted) amounts to -2.2 USD.
What is Tandem Diabetes Care Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
24%
Over the last year, the EPS (Diluted) growth was 31%. The average annual EPS (Diluted) growth rates for Tandem Diabetes Care Inc have been -74% over the past three years , -2% over the past five years , and 24% over the past ten years .